ClearPoint Neuro is a medical device company that develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's products include ClearPoint neuro system, MRI-guided drug delivery, and Thermal therapy system. Their mission is to improve and restore quality of life to patients and their families by enabling therapies for the most complex neurological disorders with pinpoint accuracy. ClearPoint Neuro's current product portfolio includes deep-brain stimulation, laser ablation, biopsy, neuro-aspiration, and delivery of drugs, biologics, and gene therapy to the brain. The ClearPoint® Neuro Navigation System has FDA clearance, is CE-marked, and is installed in 60+ Clinical & Research Centers in the US, Canada, & EU. The company's SmartFlow® cannula is being used in partnership or evaluation with 30+ individual biologics and drug delivery companies in various stages, from preclinical research to late stage regulatory trials.